Advertisement
Research Article

Community Risk Factors for Ocular Chlamydia Infection in Niger: Pre-Treatment Results from a Cluster-Randomized Trachoma Trial

  • Abdou Amza,

    Affiliation: Programme National de Lutte Contre la Cecité, Niamey, Niger

    X
  • Boubacar Kadri,

    Affiliation: Programme National de Lutte Contre la Cecité, Niamey, Niger

    X
  • Baido Nassirou,

    Affiliation: Programme National de Lutte Contre la Cecité, Niamey, Niger

    X
  • Nicole E. Stoller,

    Affiliation: F.I. Proctor Foundation, University of California San Francisco, San Francisco, California, United States of America

    X
  • Sun N. Yu,

    Affiliation: F.I. Proctor Foundation, University of California San Francisco, San Francisco, California, United States of America

    X
  • Zhaoxia Zhou,

    Affiliation: F.I. Proctor Foundation, University of California San Francisco, San Francisco, California, United States of America

    X
  • Stephanie Chin,

    Affiliation: F.I. Proctor Foundation, University of California San Francisco, San Francisco, California, United States of America

    X
  • Sheila K. West,

    Affiliation: Dana Center for Preventive Ophthalmology, Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland, United States of America

    X
  • Robin L. Bailey,

    Affiliation: Clinical Research Unit, Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom

    X
  • David C. W. Mabey,

    Affiliation: Clinical Research Unit, Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom

    X
  • Jeremy D. Keenan,

    Affiliations: F.I. Proctor Foundation, University of California San Francisco, San Francisco, California, United States of America, Department of Ophthalmology, University of California San Francisco, San Francisco, California, United States of America

    X
  • Travis C. Porco,

    Affiliations: F.I. Proctor Foundation, University of California San Francisco, San Francisco, California, United States of America, Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, United States of America, Institute for Global Health, University of California San Francisco, San Francisco, California, United States of America, Center for Infectious Disease and Emergency Readiness, University of California, Berkeley, California, United States of America

    X
  • Thomas M. Lietman,

    Affiliations: F.I. Proctor Foundation, University of California San Francisco, San Francisco, California, United States of America, Department of Ophthalmology, University of California San Francisco, San Francisco, California, United States of America, Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, United States of America, Institute for Global Health, University of California San Francisco, San Francisco, California, United States of America

    X
  • Bruce D. Gaynor mail,

    bruce.gaynor@ucsf.edu

    Affiliations: F.I. Proctor Foundation, University of California San Francisco, San Francisco, California, United States of America, Department of Ophthalmology, University of California San Francisco, San Francisco, California, United States of America

    X
  • for the PRET Partnership
  • Published: April 24, 2012
  • DOI: 10.1371/journal.pntd.0001586

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.